Igen Signs MOU With BBDC For Patented Diagnostic Technology Rights
The purpose of MOU is to continue to develop and expand a framework of cooperation between BBDC and Igen to implement a mutually beneficial program, whereby Igen will

The purpose of MOU is to continue to develop and expand a framework of cooperation between BBDC and Igen to implement a mutually beneficial program, whereby Igen will

China Baicaotang posted a net income of $4.03m, or $0.13 per diluted share, compared to $3.07m, or $0.10 per diluted share, for the same period in 2008. Operating

Alnylam said that in May 2008, the Japanese Patent Office had granted a related set of claims in the Tuschl II patent series (JP 4 095 895). The

Siemens claimed that Sitrans LVS100, which is used primarily for high or low level indication and redundancy of continuous level systems as overfill or dry run protection is

Sanofi-aventis said that the NICE appraisal committee’s preliminary recommendation is to endorse Multaq as a first choice therapeutic option after beta-blockers, which are the initial therapeutic option in

Celerion said that the acquired assets comprises of five clinical research facilities and two bioanalytical laboratories located in Lincoln, Nebraska; Neptune, New Jersey; Phoenix, Arizona; Zurich, Switzerland; and

Reportedly, the samples were evaluated in different parameters like: brain plasticity, serotonin levels and behavioral function. These parameters were selected as important indicators of the effect needed to

Alcon is expected to immediately assume all marketing, promotion and sales of Durezol. The management of Alcon is continuing to evaluate options to acquire Zirgan, an antiviral recently

MoxDuo CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain. In accordance with the recently approved IND

The new contract, which becomes effective April 1, 2010, continues Siemens’ long-standing relationship with Premier, providing members ongoing access to Siemens’ comprehensive portfolio of diagnostic systems, tests, and